← Back to Treatments
🏅 FDA Orphan Designation

Papzimeos

zopapogene imadenovec-drba

Manufacturer: Precigen, Inc.

Indicated for:
Recurrent respiratory papillomatosisOrphan

FDA-Approved Indications (1)

treatment of adults with recurrent respiratory papillomatosis

Indications & Usage

1 INDICATIONS AND USAGE PAPZIMEOS is indicated for the treatment of adults with recurrent respiratory papillomatosis. PAPZIMEOS™ is a non-replicating adenoviral vector-based immunotherapy indicated for the treatment of adults with recurrent respiratory papillomatosis. ( 1 )

💙 Support Programs

View all →
Papzimeos
Precigen, Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.